Composition of Faron Pharmaceutical's Shareholders' Nomination Board
(PR-inside.com) TURKU, FI / ACCESS Newswire / October 6, 2026 / Faron Pharmaceuticals Ltd. (HEL:FARON)(LSE:FARN), a global, clinical-stage biopharmaceutical company focused on creating innovative cancer treatments that leverage the patient's own immune system, today announces that the following members have been re-ele…
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


